Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 9,766 | 5,814 | 8,118 | 18,712 | 16,613 |
| Operating Income | -9,766 | -5,814 | -8,118 | -18,712 | -16,613 |
| Interest Expense | 9 | 7 | 8 | 6 | 0 |
| Other Income | 28 | 172 | 162 | 167 | 169 |
| Pre-tax Income | -9,747 | -5,649 | -7,964 | -18,551 | -16,444 |
| Income Tax | -9 | -167 | -31 | -61 | N/A |
| Net Income Continuous | -9,738 | -5,482 | -7,933 | -18,490 | -16,444 |
| Net Income | $-9,738 | $-5,482 | $-7,933 | $-18,490 | $-16,444 |
| EPS Basic Total Ops | -24.85 | -49.82 | -123.77 | -382.17 | -390.80 |
| EPS Basic Continuous Ops | -24.82 | -49.82 | -123.84 | -382.73 | -391.58 |
| EPS Diluted Total Ops | -24.85 | -49.82 | -123.77 | -382.17 | -390.80 |
| EPS Diluted Continuous Ops | -24.82 | -49.82 | -123.84 | -382.73 | -391.58 |
| EPS Diluted Before Non-Recurring Items | -24.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,673 | $-5,725 | $-8,094 | $-18,237 | $-16,132 |